National Research Institute
2010 Wilshire Boulevard
Los Angeles, California 90057
213-413-2500 http://www.clinical-studies.com docl@sbcglobal.net

Use our guide to learn which trials are right for you!

Located in Los Angeles, California, the National Research Institute (NRI) is a privately owned clinical research center providing clinical trial services to the pharmaceutical industry.

Over the past 25 years, NRI has:

Successfully conducted over 275 national and international Phase II, III, and IV clinical trials in therapeutic areas of:

  • Diabetes Type II
  • Hypertension
  • Lipid Metabolism
  • Obesity

Has passed three consecutive FDA audits with no cited protocol deviations or being issued 483's.

Has done very well on numerous sponsors QA audits.

  • Comprehensive mentoring and continuing education programs to assist with onsite and offsite clinical research training
  • Comprehensive SOP's
  • FAA/IATA certified staff for the shipment of hazardous materials
  • GCP/ICH trained staff
  • HIPAA trained and compliant staff
  • Shared care certified (BP)
  • Trained in various centralized 12 lead ECG
  • Trained in ambulatory cardiovascular monitoring (ABPM + Holter Monitoring)

Andrew Lewin, MD
President and Chief Executive Officer

Dr. Lewin serves as Director of NRI, is board certified in Internal Medicine and Nephrology, and has been recognized as a Specialist in Clinical Hypertension by the American Society of Hypertension. He also serves as Associate Professor of Medicine at the UCLA School of Medicine and is an Attending at Cedars-Sinai Medical Center. He has been published extensively in peer-reviewed journals on Hypertension, Diabetes, and Lipid Metabolism. He has also passed a course in Human Subjects Research Training given by the Society of Principal Investigators and in 2003 was designated a Certified Physician Investigator by the American Academy of Pharmaceutical Physicians.

  • Affiliated Physicians, all board certified in their specialties
  • 13 Clinical Research Coordinators
  • Regulatory Department
  • Quality Assurance Department
  • Administrative/Operations Staff
  • Only involved in research protocols
  • Administrative/Operations Staff devoted to research subjects
  • Approximately 33 total staff

95% of NRI's research population is Hispanic.


Cardiology/Vascular Diseases
Endocrinology
Gastroenterology
Nephrology/Urology

  • NRI is housed in a modern 7,000 square foot facility with a certified on-site laboratory
  • Maintains high quality assurance standards through weekly staff meetings, regular review of protocol summaries, rapid response to monitoring questions and company queries, and ongoing internal study audits
  • Has passed three consecutive FDA audits without protocol deviations being cited
  • Maintains a computerized patient tracking system
  • Fully HIPAA Compliant
  • Comprehensive mentoring and continuing education programs to assist with on site clinical research training
  • Comprehensive SOPs
  • IATA certified staff for the shipment of hazardous materials
  • CPR certified staff
  • GCP trained staff
  • HIPAA trained and certified staff
  • Is fluent with RDE (remote data entry)
  • All staff members are bilingual in Spanish
  • Patient recruitment is typically achieved by the following means:
    • Extensive in-house patient database (5000 current research subjects available)
    • Patient referrals
    • Advertising: television, newspaper, radio, etc.

Andrew J. Lewin
President and Chief Executive Officer
National Research Institute
2010 Wilshire Boulevard
Suite 302
Los Angeles, CA 90057
USA
213-413-2500
213-483-1494 (fax)
docl@sbcglobal.net
www.clinical-studies.com


We've found
7 trials
at this facility
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Phase 2b Study in NASH to Assess IVA337
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hypertension Clinical Trial
Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy
Status: Enrolling, Phase II
Updated: 4/3/2017
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials